Yet in the most recent month, from June to July 2025, AOM semaglutide prescribing increased by 4.9%, the largest one-month gain in first-time AOM semaglutide prescribing in over a year
Protein as a dietary foundation [A: 23:30, V: 25:15]
In animal models, imaging studies and clinical trials, including those aimed at studying the effectiveness of GLP-1RAs for the treatment of dementia syndromes, have shown that in patients with insulin resistance and T2DM, as well as dementia, there is an energy deficiency of the brain, and the heterogeneity of changes in energy metabolism depending on dementia syndromes may affect the effectiveness of GLP-1RAs [23]
This is a timely, repeated clinic topic and one that will shape the next decade of cardiometabolic care
Sermorelin has no IU conversion because it is not a biologics product standardized in that way